Britt Meelby Jensen
Elected in 2024
Core capabilities
- CEO, Ambu (2022-)
- CEO, Atos Medical (2019-2022)
- CEO, Zealand Pharma (2015-2019)
- CEO, Dako (2013-2014)
- Novo Nordisk, ending as Corporate VP, Global Marketing (2002-2013)
- Management Consultant, McKinsey & Company (2000-2002)
- Marketing Associate, PPU Maconomy (1998-2000)
Selected positions and directorships
- Member of the Board of Directors of Hempel A/S (2024-)
- Member of the Board of Trustees of the Hempel Foundation (2018-2024)
- Member of the Board of Directors of Hempel Invest A/S (2018-2024)
Education
- Cand. merc. International Marketing & Management, Copenhagen Business School (2000)
- MBA, Economics, Solvay Business School i Bruxelles (1998)